Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Goodwill & Intangibles: 2021-2025

Historic Goodwill & Intangibles for LifeStance Health (LFST) over the last 5 years, with Q3 2025 value amounting to $1.5 billion.

  • LifeStance Health's Goodwill & Intangibles fell 98.07% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year decrease of 98.07%. This contributed to the annual value of $1.5 billion for FY2024, which is 199.9% down from last year.
  • As of Q3 2025, LifeStance Health's Goodwill & Intangibles stood at $1.5 billion, which was down 98.07% from $1.5 billion recorded in Q2 2025.
  • LifeStance Health's 5-year Goodwill & Intangibles high stood at $1.5 billion for Q1 2023, and its period low was $1.5 billion during Q3 2021.
  • In the last 5 years, LifeStance Health's Goodwill & Intangibles had a median value of $1.5 billion in 2021 and averaged $1.5 billion.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first soared by 369.71% in 2022, then tumbled by 295.31% in 2024.
  • LifeStance Health's Goodwill & Intangibles (Quarter) stood at $1.5 billion in 2021, then increased by 2.08% to $1.5 billion in 2022, then dropped by 1.42% to $1.5 billion in 2023, then decreased by 2.0% to $1.5 billion in 2024, then dropped by 0.68% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.5 billion for Q2 2025, and $1.5 billion during Q1 2025.